Metabolic Dysfunction-Associated Steatotic Liver Disease: From Pathogenesis to Current Therapeutic Options.
Portincasa P, Khalil M, Mahdi L, Perniola V, Idone V, Graziani A, Baffy G, Di Ciaula A.
Int J Mol Sci. 2024 May 22;25(11):5640. doi: 10.3390/ijms25115640.
PMID:38891828
Diabetes and metabolic dysfunction-associated fatty liver disease.
Davis TME.
Metabolism. 2021 Oct;123:154868. doi: 10.1016/j.metabol.2021.154868. Epub 2021 Aug 13.
PMID:34400217
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh.
Gastroenterology. 2012 Jun;142(7):1592-609. doi: 10.1053/j.gastro.2012.04.001. Epub 2012 May 15.
PMID:22656328
Nonalcoholic fatty liver disease.
Bayard M, Holt J, Boroughs E.
Am Fam Physician. 2006 Jun 1;73(11):1961-8.
PMID:16770927
Metabolic fatty liver syndromes: where do we stand in 2024?